» Articles » PMID: 30419181

Bone Marrow-Harvesting Technique Influences Functional Heterogeneity of Mesenchymal Stem/Stromal Cells and Cartilage Regeneration

Overview
Journal Am J Sports Med
Publisher Sage Publications
Specialty Orthopedics
Date 2018 Nov 13
PMID 30419181
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Connective tissue progenitors (CTPs) from native bone marrow (BM) or their culture-expanded progeny, often referred to as mesenchymal stem/stromal cells, represents a promising strategy for treatment of cartilage injuries. But the cartilage regeneration capacity of these cells remains unpredictable because of cell heterogeneity.

Hypothesis: The harvest technique of BM may highly influence stem cell heterogeneity and, thus, cartilage formation because these cells have distinct spatial localization within BM from the same bone.

Study Design: Controlled laboratory study.

Methods: CTPs obtained from the femur of patients undergoing total hip replacement by 2 harvest techniques-BM aspiration and BM collection-after bone rasping were immunophenotyped by flow cytometry and evaluated for chondrogenic ability. The spatial localization of different CTP subsets in BM was verified by immunohistochemistry.

Results: Cells from the BM after rasping were significantly more chondrogenic than the donor-matched aspirate, whereas no notable difference in their osteogenic or adipogenic potential was observed. The authors then assessed whether distinct immunophenotypically defined CTP subsets were responsible for the different chondrogenic capacity. Cells directly isolated from BM after rasping contained a higher percentage (mean, 7.2-fold) of CD45-CD271+CD56+ CTPs as compared with BM aspirates. The presence of this subset in the harvested BM strongly correlated with chondrogenic ability, showing that CD271+CD56+ cells are enriched in chondroprogenitors. Furthermore, evaluation of these CTP subsets in BM revealed that CD271+CD56+ cells were localized in the bone-lining regions whereas CD271+CD56- cells were found in the perivascular regions. Since the iliac crest remains a frequent site of BM harvest for musculoskeletal regeneration, the authors also compared the spatial distribution of these subsets in trabeculae of femoral head and iliac crest and found CD271+CD56+ bone-lining cells in both tissues.

Conclusion: Chondrogenically distinct CTP subsets have distinct spatial localization in BM; hence, the harvest technique of BM determines the efficiency of cartilage formation.

Clinical Relevance: The harvest technique of BM may be of major importance in determining the clinical success of BM mesenchymal stem/stromal cells in cartilage repair.

Citing Articles

Extracellular matrices of stromal cell subtypes regulate phenotype and contribute to the stromal microenvironment in vivo.

Stone A, Rand E, Thornes G, Kay A, Barnes A, Hitchcock I Stem Cell Res Ther. 2024; 15(1):178.

PMID: 38886845 PMC: 11184721. DOI: 10.1186/s13287-024-03786-1.


Distinctiveness of Femoral and Acetabular Mesenchymal Stem and Progenitor Populations in Patients with Primary and Secondary Hip Osteoarthritis Due to Developmental Dysplasia.

Plecko M, Kovacic N, Grcevic D, Sucur A, Vukasovic Barisic A, Duvancic T Int J Mol Sci. 2024; 25(10).

PMID: 38791213 PMC: 11121609. DOI: 10.3390/ijms25105173.


Women's contribution to stem cell research for osteoarthritis: an opinion paper.

Velot E, Balmayor E, Bertoni L, Chubinskaya S, Cicuttini F, de Girolamo L Front Cell Dev Biol. 2024; 11:1209047.

PMID: 38174070 PMC: 10762903. DOI: 10.3389/fcell.2023.1209047.


Senescence during early differentiation reduced the chondrogenic differentiation capacity of mesenchymal progenitor cells.

Voskamp C, Koevoet W, van Osch G, Narcisi R Front Bioeng Biotechnol. 2023; 11:1241338.

PMID: 37609111 PMC: 10441241. DOI: 10.3389/fbioe.2023.1241338.


Patient Demographic Factors Are Not Associated With Mesenchymal Stromal Cell Concentration in Bone Marrow Aspirate Concentrate.

Huddleston H, Tauro T, Credille K, Dandu N, Hevesi M, Chahla J Arthrosc Sports Med Rehabil. 2023; 5(3):e559-e567.

PMID: 37388861 PMC: 10300544. DOI: 10.1016/j.asmr.2023.02.008.


References
1.
Cuthbert R, Giannoudis P, Wang X, Nicholson L, Pawson D, Lubenko A . Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration. PLoS One. 2015; 10(3):e0117855. PMC: 4356586. DOI: 10.1371/journal.pone.0117855. View

2.
Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo M . Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood. 1993; 81(7):1726-38. View

3.
Appelbaum F . The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer. CA Cancer J Clin. 1996; 46(3):142-64. DOI: 10.3322/canjclin.46.3.142. View

4.
Blashki D, Murphy M, Ferrari M, Simmons P, Tasciotti E . Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow-derived counterparts. J Tissue Eng. 2016; 7:2041731416661196. PMC: 4989583. DOI: 10.1177/2041731416661196. View

5.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View